FindTrial
Sign In

Cervical cancer prevention among HIV-infected women

Evaluation of 2 service delivery algorithms: ‘screen with an HPV test and treat’ or ‘screen with an HPV test followed by VIA and treat’ for prevention of cervical intraepithelial neoplasia in HIV- infected women attending a NACO ART centre in Pune, India: an open label randomized trial - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023349
Enrollment
600
Registered
2020-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

Intervention1: Immediate treatment of HPV positive women: All HPV infected women will be treated either by ablation or excision irrespective of the presence of any aceto-white lesion Control Intervent

Sponsors

Prayas
Lead Sponsor
Indian Council of Medical Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Women willing to sign an informed consent form

Exclusion criteria

Exclusion criteria: Women who have undergone a hysterectomy, Pregnant women, Women with a debilitating health condition, Women with a prolapsed uterus

Design outcomes

Primary

MeasureTime frame
HPV clearance in the 2 treatment armsTimepoint: HPV clearance in the 2 treatment arms—

Secondary

MeasureTime frame
Prevalence and predictors of HPV infection in HIV-infected womenTimepoint: At enrolment—

Countries

India

Contacts

Public ContactDr Smita Joshi

Prayas

smitanjoshi18@gmail.com9881132506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026